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ABSTRACT A top-down approach to mechanistic modeling of biological systems is presented and exempliﬁed with the
development of a hypothesis-driven mathematical model for single-chain antibody fragment (scFv) folding in Saccharomyces
cerevisiae bymediators BiP andPDI. In this approach,model development starts with construction of themost basicmathematical
model—typically consisting of predetermined or newly-elucidated biological behavior motifs—capable of reproducing desired
biological behaviors. From this point, mechanistic detail is added incrementally and systematically, and the effects of each addition
are evaluated. This approach follows the typical progression of experimental data availability in that higher-order, lumped
measurements are often more prevalent initially than speciﬁc, mechanistic ones. It also necessarily provides the modeler with
insight into the structural requirements and performance capabilities of the resulting detailed mechanistic model, which facilitates
further analysis. The top-downapproach tomechanisticmodeling identiﬁed three such requirements and abranched dependency-
degradation competition motif critical for the scFv foldingmodel to reproduce experimentally observed scFv folding dependencies
on BiP and PDI and increased production when both species are overexpressed and promoted straightforward prediction of
parameter dependencies. It also prescribed modiﬁcation of the guiding hypothesis to capture BiP and PDI synergy.
INTRODUCTION
In systems biology, mathematical models are used to describe
biological systems to obtain understanding of system behavior
and predict system responses (1). The type of model used and
its scale and scope vary with the desired behaviors and re-
sponses it is intended to capture and predict, the desired level of
detail, and the size of the biological system of interest. Model
types range from the highest-level regulatory graphs, which
show how species interact, to Bayesian networks, which rep-
resent conditional interactions and dependencies, to Boolean
models, which describe switching behavior, to nonlinear ODE
models, which describe dynamic behavior, to the most highly
detailed stochastic models, which capture random behavior
caused by low molecule counts (2–4). Model scale may range
frommolecular to organismal, and from low-level mechanistic
detail to higher-level lumped behavioral units. Model building
on the mechanistic scale has been referred to as ‘‘bottom-up,’’
as the model includes previously-known interactions and reg-
ulatory feedbacks, which are pared down as analysis identiﬁes
the critical, behavior-deﬁning ones. Building on the more ab-
stract, lumped behavioral scale has been referred to as ‘‘top-
down,’’ where input-output relations are used to identify and
gradually ﬁll in previously unknown interactions (5). This
work combines these two approaches by applying the top-
down methodology to biological model building on the mech-
anistic scale.
By and large, mechanistic modeling approaches have not
been formalized and are as varied as themodels and biological
systems under study themselves. Additionally, no formal
evaluation of the approaches’ applicability to or advantages in
modeling a particular biological system has been performed.
The body of circadian rhythm mathematical models demon-
strates the variety of approaches that have been employed to
describe a system largely conserved acrossmammals and fruit
ﬂies. In developing their mathematical model for the mam-
malian circadian rhythm, Forger and Peskin (6) performed an
exhaustive literature search to include many of the known
molecular interactions and mechanisms involved in the cir-
cadian clock, when a basic negative feedback loopwas all that
was necessary to reproduce experimentally observed oscil-
lations. This approach is clearly in the vein of bottom-up
model building, and it produced a mathematical model con-
taining 73 state variables (biological species) and 74 param-
eters. In stark contrast, Tyson et al. (7) sought to capture and
analyze circadian behavior in Drosophila melanogaster with
a higher-level model by reducing a three-state model con-
sisting of mRNA and two forms (monomer and dimer) of
protein to two: mRNA and total protein. Meantime, Leloup
andGoldbeter developed 10-stateDrosophila (8) and 19-state
mammalian (9) models of intermediate complexity to fulﬁll
their analytical purposes.
Still, one generalized approach to mechanistic modeling of
biological systems has been proposed (10): start by identifying
all of the reactionswithin the scope of the biological systemand
perform mass balances around the participating species. Then,
simplify the resultingmathematicalmodel consisting of a set of
nonlinear ODEswith further assumptions and approximations,
which often leads to algebraic expressions, Michaelis-Menten
kinetics, and transfer functions such as the Hill function. Fi-
nally, employ analytical tools such as sensitivity analysis to
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identify components responsible for producing certain behav-
iors and stability and bifurcation analysis to assess what be-
haviors the system is capable of producing. This process
description formalizes the bottom-up approach to mechanistic
model building.
This work describes a contrasting approach similar to that
outlined by Ideker and Lauffenburger (11), but on the scale of
mechanistic modeling: with the full desired mechanistic scope
of the model deﬁned, develop the simplest imaginable repre-
sentation of the biological system in an attempt to isolate the
backbone structure and identify motifs responsible for the
underlying behavior. Once this basic model has been estab-
lished, gradually expand it to include the desired mechanistic
details, so the contributions—or lack thereof—of these modi-
ﬁcations to system behavior may be incrementally evaluated
using systems biology analytical tools. (In the cited work by
Ideker and Lauffenburger (11), a top-down approach to bio-
logical modeling across many levels of complexity, starting
from high-level regulatory graphs and gradually appending
them with more data to transition to lower-level model types
like ODE models, is described.) This approach may then be
referred to as a top-down approach to mechanistic modeling,
and its methodology is outlined in Fig. 1. The strength of this
approach lies in the fact that it necessarily acquaints the mod-
eler with the inner workings—the behavioral contributions
originating from each mechanistic component—of a model as
the modeler constructs it.
The top-down mechanistic modeling approach also bene-
ﬁts from a growing repertoire of known biological motifs and
modules responsible for producing certain biological behav-
iors. The Escherichia coli toggle switch (12) and repressilator
(13) are two well-known examples from synthetic biology.
Other examples include positive feedback loops that can store
information from transient signals, inhibitory feedback loops
that guard against noise, and feed-forward loops that accel-
erate responses (14).Muchwork has gone into identifying and
cataloguing recurring structural motifs within a variety of
gene regulatory, protein-protein interaction, and other bio-
logical networks (15–19), with the intent of eventually char-
acterizing their dynamic properties (21–22). One of the most
extensive—though still quite limited—collections of already-
characterized biological behavior motifs has been compiled
by Wolf and Arkin (23). Familiarity with these motifs and
modules can aid in construction of the basic backbone
structure by allowing one to identify more readily the com-
ponents and interactions that will be necessary to reproduce
experimentally observed behaviors.
To demonstrate the top-down approach to mechanistic
modeling, this work will develop a model for single-chain
antibody fragment 4-4-20 (scFv) translocation into and folding
within the endoplasmic reticulum (ER) lumen of Saccharo-
myces cerevisiae, or baker’s yeast, by the chaperone binding
protein (BiP) and foldase protein disulﬁde isomerase (PDI).
The motivation for this study comes from the fact that single-
chain antibodies have a variety of applications in biotechnol-
ogy and medicine (24,25) and serve as useful models for the
expression of other disulﬁde bond-containing therapeutic
proteins. Additionally, yeast is a frequently-used platform,
because it combines the ease of microbial genetics and growth
characteristics with post-translational, eukaryotic processing
(26–28).Thegoal of using systemsbiology to study this system
is to optimize production of scFv in the S. cerevisiae platform.
It has been shown that overexpressing BiP or PDI indi-
vidually increases scFv yields in the microorganism but
overexpressing both species simultaneously ampliﬁes yields
beyond both of those individual increases (26,29). Xu et al.
(29) hypothesized that these experimentally observedBiP and
PDI dependencies and ampliﬁcation resulting from co-over-
expression originate from BiP assisting in/accelerating un-
folded scFv translocation into the ERwith no effect on protein
folding rates and PDI actually facilitating protein folding. In
this line of reasoning, increasing BiP increases the pool of
scFv to be folded, and increasing PDI increases the amount of
that pool that is exported from the cell. Amathematical model
was developed using the top-down approach to mechanistic
modeling to test this hypothesis. Steady-state analysis was
employed as a primary analytical method for evaluating
model performance. As the top-down approach was applied,
its strengths were clearly highlighted as it identiﬁed a critical
motif and three requirements for reproduction of experi-
mentally observed BiP and PDI dependencies and enhanced
scFv production with both species overexpressed, while
suggesting that the hypothesis incompletely describes po-
tentially more complex interactions between BiP and PDI in
scFv folding that yield synergistic effects.
FIGURE 1 Overview of the top-down approach to mechanistic biological
modeling methodology presented in this work. Inputs and outputs to the
methodology are indicated with dotted arrows; methodology ﬂow is indi-
cated by solid arrows.
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MODEL DEVELOPMENT METHODOLOGY
Establishing desired model behaviors
In implementing the top-down approach, one ﬁrst identiﬁes the experimental
behavior(s) one wishes to capture with the mathematical model. One beneﬁt
of the top-down approach is that it begins with the construction of a high-
level mathematical model, so the approach may be readily implemented even
when existing biological data is sparse (which is often the case with bio-
logical systems). To reiterate, in the case of scFv folding, the model must
display BiP and PDI dependence in secreted scFv production and increased
scFv production when both BiP and PDI are overexpressed than when either
is overexpressed independently. These behaviors are captured in a key set of
experimental data from Xu et al. (29), reproduced in Fig. 2 A.
Establishing desired model details
Next, one mines the experimental literature for known and hypothesized in-
teractions and mechanistic details desired for inclusion in the ﬁnal mechanistic
model. In doing so, the model’s scope is established. Since the scFv folding
model was to be used for evaluating the validity of the hypothesis of Xu et al.
(29), it was to include BiP assisting in unfolded scFv (UscFv; a detailed key to
nomenclature, including deﬁnitions for preﬁxes such as the U-, used in this
work is provided in Table 2) translocation into the ER and PDI catalyzing
protein folding. Other details desired for inclusion in the model were those
associatedwith transcription, translation, and post-translational translocation of
the scFv; UscFv, BiP, and PDI binding states; and relative UscFv folding/
misfolding rates in each of those binding states. Inclusion of these details would
also require three compartments: the nucleus, cytoplasm, and ER.
Constructing a backbone model
With the scope of the detailed mechanistic model established, one then
identiﬁes the components necessary for construction of a backbonemodel, the
bare minimum that is required for capturing the desired experimental be-
haviors. This step may be facilitated by searching the literature for elements
(modules, motifs, and interactions) known to be responsible for producing
certain biological behaviors for homologies to the system at hand. If one or
more plausible matches is/are found, the corresponding element(s) may be
applied to the backbone model structure. Experimental validation of the uti-
lization of such elements—notably, combinations thereof in gene regulatory
networks—in mathematical model construction to represent and predict bi-
ological behavior was performed by Guido et al. (30). If no known modules,
motifs, or interactions are appropriate for use in the backbone model, the
modeler will need to identify such underlying mechanisms independently.
In the scFv folding example, there was no precedent for the experimen-
tally observed scFv folding dependencies, so the latter approach was un-
dertaken. Guidance in constructing a backbone model structure for this
system originated from the hypothesis of Xu et al. (29). It was possible to
capture this hypothesis most fundamentally in a two-state mathematical
model, where UscFv entered the ER in a second-order, BiP-dependent step,
and the UscFv folded in preparation for secretion (SscFv) in a second-order,
PDI-dependent step. This reaction scheme is illustrated as Model 1 in Fig. 3,
and its parameters are described and assigned values in Table 3.
When developing a backbone (or any mathematical) model, enumerating
all assumptions and simpliﬁcations is an effective means of systematizing the
process. If and when a model fails to capture the experimental behaviors,
assumptions and simpliﬁcations may be altered or relaxed in a methodical
fashion. Only when all of these potential alterations and relaxations have
been exhausted should the insight gained from the unsuccessful modeling
attempt be applied toward formulating a new model. The assumptions and
simpliﬁcations used in construction of the scFv folding backbone model are
listed below and explained in the following paragraph.
1. All reactions were modeled using lowest-order, deterministic kinetics.
2. No scFv protein of any form was initially present in the system.
3. Unfolded protein entry to the ER was assumed to have a ﬁrst-order
dependency on BiP.
4. Folding/secretion was assumed to have a ﬁrst-order dependency on PDI.
5. Pools of 1 3 103 scFv mRNAs, 3.37 3 105 free BiPs, and 5.24 3 105
free PDIs participated in their respective reactions, as described in the
reaction equations and illustrated in Fig. 3, and were not consumed.
6. No scFv misfolding or degradation reactions were included.
FIGURE 2 (A) Experimental scFv se-
cretion data reproduced fromXuet al. (29).
‘‘O.’’ refers to ‘‘overexpressed’’. Over-
expression levels are provided in the refer-
ence. (B) In silico reproduction of this data,
using the fully detailed mathematical
model. (C) 50 h time points for all model
simulationsnormalized to the respective50
h experimental time points in Fig. 2A (e.g.,
the 50 h O.BiP model time points are
divided by the experimental 50 h O.BiP
data point). The similarly-scaled experi-
mental 50h timepoints towhich this data is
compared are represented by the horizontal
dashed line of value one. Thus,models that
have normalized 50 h time points close to
one for all BiP and PDI expression levels
are most successful at reproducing the
experimental data. Scaled error bars for
the experimental 50 h data point with the
highest standard deviation (0.2 relative
units for O.PDI) are provided on the plot
(O.BiP and O.BiP1PDI had standard de-
viationsof0.05 relativeunits).BiPandPDI
overexpression levels and the unscaled
simulation and experimental values used
to produce this plot are provided inTable 1.
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7. All properly folded scFv was assumed to proceed to the Golgi and
ultimately be secreted.
8. All compartments were assumed to be well mixed.
Assumptions 1 and 7 will be common to all mathematical models presented
in this article. The second assumption was meant to mimic the experimental
conditions under which the invalidation data were taken, where transfer to
galactose-containing medium at time ¼ 0 initiated scFv production. As-
sumptions 3 and 4 were meant to capture in basic form the central concepts of
the hypothesis of Xu et al. (29), and the ﬁrst-order dependencies arose from
Assumption 1. Assumption 5 arose from literature-derived values for these
concentrations (31–33), and embedded within it was the further, critical
assumption that all BiP and PDI was available for reaction with scFv, and
none was sequestered away by competing reactions/species. Assumption 6
was made for simplicity, even though it is well documented that proteins
terminally misfold and are removed from the ER via ER-associated degra-
dation (34). Assumption 7 was for pure model simpliﬁcation reasons.
Assumption 8 was also made for simpliﬁcation, and although preliminary
work exists suggesting that BiP is not homogeneously distributed throughout
the ER (35), Fig. 4 A suggests these effects will not alter BiP dependency
results presented here. The reaction equations follow. State deﬁnitions are
provided in Table 2, rate constant deﬁnitions and values are provided in
Table 3, and rate constant derivations are provided in the Appendix.
d½UscFv
dt
¼ k1b½scFvmRNA½BiP  k2b½UscFv½PDI: (1)
d½SscFv
dt
¼ k2b½UscFv½PDI: (2)
All mathematical model simulations in this work were performed using
MATLAB Simulink using the ode15s solver (TheMathWorks, Natick, MA).
Fig. 2B, which contains trajectories from the fully detailedmodel, exempliﬁes
typical simulation trajectories for all mathematical models from in silico runs
intended to replicate the experimental results of Xu et al. (29) in Fig. 2 A. All
model trajectories displayed the observed linear behavior, so that a concisely
effective method for evaluating model performance in replicating the exper-
imental trajectories could be developed by comparing 50 h time point values,
as demonstrated in Fig. 2C. These values, listed in Table 1, were scaled by the
experimental data points to facilitate this simulation-experiment comparison.
The table also lists the multiples by which BiP and PDI were overexpressed
to yield the model results that most closely matched experiment, all of
which are within an order-of-magnitude of the experimental values listed in
the table, except for Model 8. Error bars from the experimental data point
with the largest standard deviation (O.PDI at 50 h) were also included in the
ﬁgure. Model numbers in the ﬁgure correspond to their assignments in
FIGURE 3 Schematics for the developmental models and their modiﬁcations. Models 1 and 2 were used in backbone model development. Models 3–6
represent the original four permutations of models containing explicit BiP and PDI binding and release. When Modiﬁcation A was applied to these models,
they were designated Models 3*6*, which are not schematized here. Model 7 represents a binding permutation model where the branched dependency-
degradation competition motif for BiP was introduced by eliminating BiP’s role in post-translational translocation. Model 8 depicts a ﬁnal permutation where
UscFv may freely move between BiP and PDI binding states and has Modiﬁcation A implemented in it. The ﬁgure legend that deﬁnes species, preﬁxes, icons,
and rate constant subscript preﬁxes and sufﬁxes is in Table 2. Parameter deﬁnitions and values are in Table 3.
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Fig. 3 and the text, and asterisks indicate models that have been modiﬁed
with Modiﬁcation A, which is also schematized in Fig. 3.
One beneﬁt of developing a backbone model is it generally facilitates
analysis by eliminating the clutter associated with more detailed models. For
example, with such a simple model for scFv folding, it was possible to derive
analytically the steady-state production of SscFv from the model equations
and evaluate its dependencies on BiP and PDI concentrations directly. Steady
state was achieved within the ﬁrst time step of the simulations, 1 3 103 s,
which is consistent with experiments that show pro-scFv (UscFv) reaching
steady-state levels within 10 and 60 min of the initiation of scFv production.
Consequently, the steady-state analysis was appropriate. For this most basic
mathematicalmodel, the steady-state SscFvproduction rate ((d½SscFv=dt)SS;
(d½SscFv=dt) sufﬁxes deﬁned in Table 2), which was derived by expressing
the SscFv production rate in terms of system parameters after having set the
other states’ time dependencies to zero, was
d½SscFv
dt
 
SS
¼ k1b½BiP½mRNA: (3)
This equation demonstrates that SscFv production was totally independent of
PDI levels in this mathematical model. scFv ﬂux through the system was
constant and determined at the ER-entry step, modulated by BiP. Increasing/
decreasing PDI levels would only decrease/increase, respectively, UscFv
levels, but the ﬂux would remain the same. As a result, this model was
incapable of reproducing the experimentally observed scFv folding depen-
dency data. These results indicated a fault in the backbonemodel formulation.
As previously discussed, modiﬁcations to the model should be made by
systematically altering or relaxing assumptions and simpliﬁcations before
discarding it completely. Assumption 6 was the ﬁrst to be altered in the scFv
folding model, as it was arguably one of the weakest. This alteration was
justiﬁed biologically: in vivo, if a protein is not successfully folded after
some time, it proceeds down the ER-associated degradation pathway, where
it is retro-translocated from the ER to the cytoplasm and degraded (reviewed
in (34)). Hence, protein folding may be viewed as a competition between
achieving a properly folded state or a terminally misfolded state.
To include this detail in the backbone model, a generic degradation
pathway was added to the UscFv state, illustrated as Model 2 in Fig. 3. Thus,
Assumption 6 from the previous model was replaced with
6. UscFv misfolds/degrades in a ﬁrst-order reaction
and all other assumptions remained the same. The corresponding model
equations and steady-state SscFv production rate follow.
d½UscFv
dt
¼ k1b½scFvmRNA½BiP
 k2b½UscFv½PDI  km5½UscFv: (4)
d½SscFv
dt
¼ k2b½UscFv½PDI: (5)
d½SscFv
dt
 
SS
¼ k1b½BiP½mRNA½PDI
km5
k2b
1 ½PDI
: (6)
From the steady-state SscFv production rate, it may be seen that the degra-
dation pathway introduced PDI dependency, the magnitude of which varies
depending on the ratio of the degradation to folding rate constants. Themodel
predicts that as the assisted folding rate constant dominates over degradation,
PDI dependence diminishes. For the literature-derived parameter values used
in the model (see Appendix for all parameter derivations), there was sufﬁ-
cient PDI dependence to capture both of the two key experimental invali-
dation behaviors: scFv secretion showed a similar BiP- and PDI-dependency
and was enhanced when BiP and PDI were simultaneously—as opposed to
individually—overexpressed (Fig. 2 C). Based on this signiﬁcant improve-
ment in model performance, the ﬁrst in a series of three requirements for the
ultimate detailed model to reproduce the experimental data was formulated:
Requirement No. 1
Competition between degradation/misfolding and accelerated folding by
PDI is necessary for PDI dependence.
Thus, with the addition of UscFv degradation, a successful backbone
model was constructed, and the hypothesized folding process remained viable.
Further model development
Upon formulation of a successful backbonemodel, the top-down approach to
mechanistic modeling proceeds with the gradual supplementation of the
model with mechanistic detail until the desired level of detail, deﬁned when
the model’s scope was being elaborated, has been reached. The order in
which these details are added and the quantities added at a time will depend
upon the model and its intended use and will consequently require the dis-
cretion of the modeler. One consideration to make when proceeding, though,
is that one purpose of incrementally appending the model is to enable the
modeler to observe and evaluate the discrete effects produced by each al-
teration. Consequently, it would be desirable to design each increment so as
to maximize the insight gained from implementing it. This process is dem-
onstrated with the scFv folding model below.
For the scFv folding model, further translocation or folding details could
not be reasonably added without ﬁrst including explicit BiP and PDI
binding and release of the UscFv: it was desired to have BiP bind the UscFv
at the translocon for entry to the ER, at which point BiP could theoretically
release it, or PDI could also bind the BiPUscFv complex. It has been hy-
pothesized that PDI is largely incapable of binding unfolded protein on its
own in its foldase capacity, and BiP is responsible for making unfolded
protein accessible for PDI binding (36), thus increasing the extent to which
BiP and PDI cooperate in the protein folding process. The model was later
used to assess this hypothesis. UscFv could also transition between the
BiPPDIUscFv and PDIUscFv states with the respective release or binding
of BiP. True to the top-down modeling approach, these binding states were
added incrementally to evaluate their effects on the ability of the model to
reproduce the experimentally observed BiP and PDI scFv folding depen-
FIGURE 4 Curves depicting the Michaelis-Menten-like dependencies of
steady-state SscFv production on BiP (A) and PDI (B) levels for Models
3*6* and 8.
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dencies. The resulting four model permutations are schematized as
Models 3–6 in Fig. 3. Parameter descriptions and values are provided in
Table 3.
With the model constructs established, it was then necessary to as-
sign the folding and misfolding rates associated with each of the binding
states. Derivation and references for the actual rate values are presented
in the Appendix, but qualitative descriptions and logic are presented here. It
is thought that chaperone proteins such asBiP do not actually promote faster
protein folding but rather protect the unfolded protein against misfolding by
binding hydrophobic regions (reviewed in (37)). Hence, a BiP-bound un-
folded protein would be expected to fold at approximately the same rate as
an unbound one, however its effective misfolding rate would be slower than
the unbound one. A PDI-bound unfolded protein would be expected to have
a faster folding rate but a similar misfolding rate (ignoring PDI’s proposed
chaperone behavior (38–40), reviewed in (41)) to an unbound one, and a
BiP- and PDI-bound unfolded protein would be expected to have both a
faster folding rate and a slower misfolding rate. Assumptions and simpli-
ﬁcations for the four model permutations follow:
1. All reactions were modeled using lowest-order, deterministic kinetics.
2. No scFv protein of any form was initially present in the system.
3. Unfolded protein entry to the ER was assumed to have a ﬁrst-order
dependency on BiP.
4. Folding/secretion was assumed to be ﬁrst-order and faster for BiP-PDI-
bound and PDI-bound than BiP-bound and unbound UscFv.
5. A pool of 1 3 103 scFv mRNAs participated in the lumenal UscFv
production reaction but was not consumed.
6. 3.37 3 105 free BiPs and 5.24 3 105 free PDIs were available for
UscFv binding and were consumed in the binding reactions and
regenerated upon release.
7. All properly folded scFv was assumed to proceed to the Golgi and
ultimately be secreted.
8. Misfolding/degradation was assumed to be ﬁrst-order and equivalent
for both BiP-PDI-bound BiP-bound UscFv but faster for both unbound
and PDI-bound UscFv.
9. BiP binding was required for PDI binding to occur.
10. Multiple binding by BiP and PDI was ignored for simplicity, and
folding/misfolding rates were based on overall folding/misfolding rates,
as derived in the Appendix.
11. All compartments were assumed to be well mixed.
Due to the increasing size and number of models, their ODEs have been
relegated to the Appendix, though it must be noted that the initial step of
importing UscFv to the ER (BiPUscFv production term) was always
represented by k1[BiP][scFv mRNA] in the BiPUscFv equations, with k1
representing the effective second-order scFv translation and translocation rate
into the ER. Analytical solutions for the model permutations’ steady-state
SscFv production rates are presented below (Model 3, Eq. 7; Model 4, Eq. 8;
Model 5, Eq. 9; and Model 6, Eq. 10). In deriving these solutions, a further
assumption was employed to make the algebra tenable: unbound BiP and
PDI were sufﬁciently abundant over UscFv, so their concentrations were not
altered by bindingUscFv. This assumption held during simulations, where BiP
and PDI concentrations remained 3.37 3 105 and 5.24 3 105 molecules, re-
spectively, while bound species never exceeded 100 molecules.
d½SscFv
dt
 
SS
¼ k1½BiP½scFvmRNAðk3ðkr21 k41 km4Þ1 k2½PDIk4Þðk31 km3Þðkr21 k41 km4Þ1 k2½PDIðk41 km4Þ : (7)
d½SscFv
dt
 
SS
¼
k1½BiP½scFvmRNA

k31
k4k2½PDI
kr21 k41 km4
1
k7kr6
k6½BiP1 k71 km7

kr6 1 k6½BiP
k6½BiP1 k71 km7
 
1 k2½PDI 1 kr2
kr21 k41 km4
 
1 k31 km3
: (8)
d½SscFv
dt
 
SS
¼ k3k1½BiP½scFvmRNA
k2½PDI1 k31 km3 1
k3kr2
k2½PDI1 k31 km31 k41
k5kr6
k6½BiP1 k51 km5
 
3
k1½BiP½scFvmRNAk2½PDI
ðk2½PDI1 k31 km3Þ kr6 1 k6½BiP
k6½BiP1 k51 km5
 
1 kr2 1 k2½PDI
k2½PDI1 k31 km3
  
8><
>:
9>=
>;
: (9)
d½SscFv
dt
 
SS
¼ k31 k2½PDI
kr21kr6 1 k6½BiP
k6½BiP1 k51 km5
 
1 k41 km4
k41
k5kr6
k6½BiP1 k51 km5
 
1
k7kr6
k6½BiP1 k71 km7
8><
>:
9>=
>;
3
k1½BiP½scFvmRNA
kr6 1 k6½BiP
k6½BiP1k71km7
 
1k2½PDI 1 kr2
kr21kr6 1 k6½BiP
k6½BiP1k51km5
 
1k41km4
0
BB@
1
CCA1k31km3
8>>>>>><
>>>>>:
9>>>>>>=
>>>>>;
: (10)
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As may be observed in these equations, the aforementioned
BiPUscFv production term, k1[BiP][scFv mRNA], appears in the numerator
in each of the model permutations’ expression for steady-state SscFv pro-
duction, indicating that production in each permutation was largely linearly
dependent on BiP concentration. On the other hand, production dependence on
PDI concentration assumed a Michaelis-Menten-like form. The linear BiP
dependence overpowered PDI’s contribution for a range of BiP and PDI
concentrations (not shown), so to reproduce the experimental dependencies,
it was necessary to overexpress PDI an order-of-magnitude times more than
BiP (Fig. 2 C, Table 1). To modify this behavior, the assumptions and
simpliﬁcations that went into deriving the models were reevaluated for al-
terations.
From the backbone model development, it was observed that including
a degradation pathway to compete with a species-dependent pathway in-
stilled the Michaelis-Menten-like dependence on PDI in the steady-state
SscFv production rate expression. This branched dependency-degradation
competition motif could then be applied to BiP’s role in translocation, so
steady-state SscFv production would have a Michaelis-Menten-like de-
pendence on both BiP and PDI. Since BiP catalyzing translocation of
UscFv into the ER was the dependency step, a degradation step, such as
cytoplasmic scFv mRNA degradation, was necessary. A schematic repre-
sentation of this modiﬁcation is presented in Fig. 3 (Modiﬁcation A); it is
shown implemented in Model 8; and Models 3–6 with this modiﬁcation will
be denoted with an asterisk as Models 3*6*. This theoretical alteration
translated into the alteration of Assumption 5, whose revised version appears
below:
5. scFv transcription was modeled by a step input of scFv mRNA that
could be consumed by cytoplasmic degradation and lumped transla-
tion/translocation into the ER to yield 1 3 103 scFv mRNA during
steady-state SscFv production.
The fully modiﬁed differential equations for each model permutation appear
in the Appendix; however, it is instructive to analyze the differential equation
for scFv mRNA production—common to all model permutations—which
resulted from the revised Assumption 5:
d½scFvmRNA
dt
¼ VscFv  k1½BiP½scFvmRNA
 kd½scFvmRNA: (11)
When this equation is analyzed at the steady state,
½scFvmRNA ¼ VscFv
k1½BiP1 kd; (12)
a steady-state BiPUscFv production term (i.e., the BiP-dependent translo-
cation rate) for the alteredmodels may be derived:VscFvk1½BiP=(k1½BiP1kd):
This term, with its distinct Michaelis-Menten-like dependence on BiP,
supplants k1[BiP][scFv mRNA] in the previous models’ expressions for
steady-state SscFv production (Eqs. 7–8), so that both BiP and PDI have
similar concentration dependencies. The similar steady-state BiP and PDI
SscFv production value dependencies shown in Fig. 4 and the comparable
BiP and PDI relative overexpression levels required to reproduce the
experimentally observed BiP and PDI dependencies in Fig. 2 provided in
Table 1 reinforce this result with simulation data. Consequently, an important
biological structural motif has been identiﬁed, and a second requirement for
the scFv folding model is claimed:
Requirement No. 2
Assumingpost-translational translocation isBiP-dependent, competitionbetween
the translocation step and cytoplasmic degradation of the translocating species is
required to make BiP and PDI expression level dependencies comparable.
It may also be noted that another way to introduce a branched dependency-
degradation competition motif for BiP in the scFv folding model is by elimi-
nating BiP’s participation in post-translational translocation of the UscFv to the
ER (Model 7 in Fig. 3). In this case, UscFv enters the ER unbound, where it may
degrade by folding or misfolding (degradation branch of the motif) before being
reversibly bound by BiP (dependency branch). The steady-state BiPUscFv
production term in this case, k6½BiP(k1½scFvmRNA1kr6½BiP  U)=(k6½BiP1
k71km7); demonstrates Michaelis-Menten-like dependency, so that the expres-
sion for steady-state SscFv production thus shows such a dependence on both
BiP and PDI:
TABLE 1 Relative BiP and PDI overexpression levels used to produce the corresponding relative SscFv levels 50 h into the
in silico experiments (columns 2–14), which were normalized to provide the scaled relative SscFv level data found in Fig. 2 C
Model 1 2 3 3* 4 4* 5 5* 6 6* 7 8 Detailed Experiment
Relative overexpression level
BiP 2 1.5 1.5 40 1.5 40 1.5 20 2 40 3 100 2 3–12
PDI 2 2 10 40 10 40 10 80 10 40 20 15 4 6–8
Relative scFv level
Nominal 1.8 1.1 1.5 1.4 0.97 0.90 1.4 1.4 0.97 0.90 1.5 0.87 0.99 1.0
O.BiP 3.7 1.7 2.2 2.3 1.5 1.6 2.2 2.2 2.0 1.7 2.1 1.3 1.5 1.2 6 0.1
O.PDI 1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.9 1.6 6 0.4
O.BiP 1 PDI 3.7 2.8 2.8 3.0 2.8 3.0 2.8 2.9 3.7 3.0 3.1 2.9 2.7 3.4 6 0.2
Experimental valuesof theBiPandPDIoverexpression levels and the relativeSscFv levels towhich thedata inFig. 2Cwerenormalizedare also included in theﬁnal column
for comparison. Key: O., overexpressed; O.BiP, overexpressed BiP; O.PDI, overexpressed PDI; O.BiP1PDI, overexpressed BiP and PDI; Nominal, no overexpression.
d½SscFv
dt
 
SS
¼ k7k1½scFvmRNA
k6½BiP1 k71 km71
k7kr6
k6½BiP1 k71 km71 k31
k4k2½PDI
kr21 k41 km4
 
3
k6k1½BiP½scFvmRNA
ðk6½BiP1 k71 km7Þ kr6 1 k6½BiP
k6½BiP1 k71 km7
 
1 k2½PDI 1 kr2
kr21 k41 km4
 
1 k31 km3
 
8>><
>:
9>>=
>;
:
(13)
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From this result, one may conclude that the hypothesis of Xu et al. (29) is not
exclusive in possessing the ability to reproduce experimentally observed BiP
and PDI dependencies in scFv folding, though the BiP-independent trans-
location model is inconsistent with experimental evidence of BiP-scFv as-
sociations (42).
In returning to the hypothesis-based model development, there were four
permutations of the model iteration that included explicit BiP and PDI
binding details that were capable, to some extent, of capturing the experi-
mentally observed BiP and PDI dependencies. One ﬁnal permutation was
established to evaluate the hypothesis that PDI requires BiP-boundUscFv for
binding as a foldase, as previously described. This ﬁnal permutation, which
represented the alternative case where PDI may bind UscFv directly, is
represented by Model 8 in Fig. 3 and already has Modiﬁcation A im-
plemented in it.
While the analytical solution for steady-state SscFv production in this
ﬁnal model permutation is fairly complex (see Appendix), it does exhibit
Michaelis-Menten-like dependencies on both BiP and PDI. However, it
deviated from experiment by an order of magnitude in the amount of BiP and
PDI overexpression (Table 1) it required to reproduce the data in Fig. 2 A. A
further means to evaluate model performance would be necessary to draw
more deﬁnitive conclusions on this model permutation and the hypothesis
that generated it.
Up to now, focus has been placed on evaluating the model permutations’
ability to reproduce BiP and PDI dependencies. The other key experimental
behavior desired for a successful mathematical model to exhibit was enhanced
SscFv production by simultaneously—over independently—overexpressed
BiP and PDI. The unscaled results recorded in Table 1 show that this behavior
was in fact displayed by all of the models.
Xu et al. (29) proposed that the enhanced SscFv production from simul-
taneous BiP and PDI overexpression resulted from cooperativity, or syner-
gistic effects, between the two species in the folding process. In the context of
their hypothesizedmodel, where BiP and PDI act serially upon scFv, synergy
is mathematically deﬁned as a steady-state SscFv production rate when both
BiP and PDI are overexpressed ((d½SscFv=dt)SS;O:BiP1PDI) that is greater than
the product of the production rates when each of the species is overexpressed
independently ((d½SscFv=dt)SS;O:BiP3(d½SscFv=dt)SS;O:PDI) using the same
relative overexpression levels. When these rates are normalized by the pro-
duction rate when neither species is overexpressed ((d½SscFv=dt)SS;nominal),
the following ratio
indicates serial synergy for values .1. An experimental synergy value was
obtained by evaluating the slopes for each BiP/PDI overexpression level data
set in Fig. 2 A and implementing them in Eq. 14 as the respective steady-state
SscFv production rates. The value, 1.9, supports the proposal that the ex-
perimental data reﬂects synergistic behavior between BiP and PDI.
The models were also tested for their ability to display serial synergy,
and results are plotted in Fig. 5. The synergy values in the plot are for BiP and
PDI overexpression levels of the same relative amounts (e.g., both BiP and
PDI were overexpressed 10-fold, 20-fold, etc.), though similar trends were
observed for all other calculated permutations in BiP and PDI levels in the
10- to 100-fold overexpression range (e.g., BiP overexpressed 10-fold and
PDI overexpressed 20-fold, BiP overexpressed 20-fold, and PDI overex-
pressed 10-fold, etc.). From the plot, it may be observed that none of the
models exhibited serial synergy, indicating the likelihood of more complex
interactions between BiP and PDI in the scFv folding process
than hypothesized by Xu et al. (29), which may include the involvement
of other species, such as co-chaperones, and/or PDI’s chaperone activity.
At this stage of model development, there was one ﬁnal technical issue to
be addressed pertaining to the biological validity of Assumption 6: 3.37 3
105 free BiPs and 5.243 105 free PDIs were available for UscFv binding and
were consumed in the binding reactions and regenerated upon release. BiP
has many roles in the ER (most reviewed in (37); karyogomy function de-
scribed in (43)) and, consequently, interacts with many proteins there, and
PDI accelerates the folding of any disulﬁde bond-containing species. To
better represent this biological sequestration of BiP and PDI from UscFv, a
pool of total (non-scFv) unfolded protein was introduced to which BiP and
PDI could bind. This modiﬁcation is schematized asModiﬁcation B in Fig. 3.
Upon implementation of Modiﬁcation B, one also introduces a useful means
of tuning SscFv production rates.
FIGURE 5 Curves depicting the serial synergy values (serial synergy
deﬁned by Eq. 14) calculated for Models 3*6* and 8 over a variety of BiP
and PDI overexpression levels. In this plot, ‘‘Relative BiP and PDI’’
indicates the factor by which both BiP and PDI were overexpressed for that
particular value. Values for further permutations in relative BiP and PDI
overexpression were calculated, but they displayed similar relative behavior
and are not included on this plot for simplicity.
d½SscFv
dt
 
SS;O:BiP1 PDI
d½SscFv
dt
 
SS;nominal
d½SscFv
dt
 
SS;O:BiP
d½SscFv
dt
 
SS;nominal
3
d½SscFv
dt
 
SS;O:PDI
d½SscFv
dt
 
SS;nominal
¼
d½SscFv
dt
 
SS;O:BiP1PDI
3
d½SscFv
dt
 
SS;nominal
d½SscFv
dt
 
SS;O:BiP
3
d½SscFv
dt
 
SS;O:PDI
; (14)
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That is, as available BiP and PDI levels are altered through introduction of
this pool of generic unfolded protein, SscFv production dependencies are
also altered per the BiP and PDI dependency curves in Fig. 4, as long as free
BiP and PDI are available in excess (the assumption under which the de-
pendency curves were generated). If either BiP or PDI concentrations ap-
proach or fall below UscFv levels, SscFv production dependence will be
dominated by the limiting species—behavior that is not captured by the
curves. To control the amount of BiP and PDI sequestered away by generic
unfolded protein, the amount of generic unfolded protein present and/or
BiP and PDI’s afﬁnities for unfolded protein may be altered. In this work,
the amount of generic unfolded protein was kept constant at 1.53 105, while
the afﬁnities were altered, so that an excess of 1.873 105 unbound BiP and
3.74 3 105 unbound PDI remained at steady state.
Completion of the fully detailed model
Even though all model permutations were similarly capable of capturing
desired BiP and PDI dependencies and enhanced scFv production when both
BiP and PDI were overexpressed, Model 6* was selected for further devel-
opment, because its mechanistic structure most resembled the desired fully
detailed model structure. In transforming Model 6* to the fully detailed
model, details pertaining to scFv transcription and translation and an extra
step to the post-translational translocation process were added (Fig. 6; legend
in Table 2) with no effect on model performance with regard to capturing BiP
and PDI dependencies and enhanced scFv production with BiP and PDI
overexpression (Fig. 2 C). Additionally, it should be noted that in the fully
detailed model, BiP-dependent translocation competes with cytoplasmic
unfolded scFv rather than scFv mRNA degradation, but Michaelis-Menten-
like dependence on BiP is retained because the branched dependency-deg-
radation competition motif and Requirement No. 2 are conserved. The list of
model assumptions and simpliﬁcations for the fully detailed model follows.
SystemODEs are included in the Appendix. Parameters, some of which were
renamed from the simpler models, are listed in Table 3.
1. All reactions were modeled using lowest-order, deterministic kinetics.
2. NoscFv transcript or protein of any formwas initially present in the system.
3. BiP binds UscFv at the translocon in a second-order reaction, and
UscFv enters in a ﬁrst-order reaction step.
4. Folding/secretion was assumed be ﬁrst-order and faster for BiP-PDI-
bound and PDI-bound than BiP-bound and unbound UscFv.
5. scFv transcription was a step input.
6. 3.37 3 105 total BiP and 5.24 3 105 total PDI were available for
UscFv and general unfolded protein binding and were consumed in the
binding reactions and regenerated upon release.
7. All properly folded scFv was assumed to proceed to the Golgi and
ultimately be secreted.
8. Misfolding/degradation was assumed be ﬁrst-order and equivalent for
both BiP-PDI-bound BiP-bound UscFv but faster for both unbound and
PDI-bound UscFv.
9. BiP binding was required for PDI binding to occur.
10. Multiple binding by BiP and PDI was ignored for simplicity, and
folding/misfolding rates were based on overall folding/misfolding rates,
as derived in the Appendix.
11. Cytoplasmic species (scFv mRNA and UscFv) degraded.
12. All compartments were assumed to be well mixed.
FIGURE 6 Schematic for the fully detailed scFv folding model. State numbers are provided for comparison with equations in the code. The ﬁgure legend that
deﬁnes species, preﬁxes, icons, and rate constant subscript preﬁxes and sufﬁxes is in Table 2. Parameter deﬁnitions and values are provided in Table 3.
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RESULTS
Having developed a detailed mechanistic model using the
top-down approach, analysis could proceed. The top-down
model development process enables the more efﬁcient and
effective application of analytical methods, reviewed in
Aldridge et al. (10), due to the insights one has attained in
incrementally constructing the model. The insights gained in
the scFv folding model development guided the prediction
and evaluation of parameter dependencies of SscFv pro-
duction. Development of the backbone model for scFv
folding identiﬁed the core processes required for reproduc-
TABLE 2 Deﬁnitions for all states found in the equations and in Figs. 3 and 6, recurring preﬁxes used in state names, subscripts
for SscFv production in the equations, all icons found in the aforementioned ﬁgures, and recurring preﬁxes and sufﬁxes used
in parameter subscript labels
State name State deﬁnition
BiP BiP (binding protein).
BiPPDIUP BiP- and PDI (protein disulﬁde isomerase)-bound generic unfolded protein.
BiPPDIUscFv BiP- and PDI-bound unfolded scFv (single-chain 4-4-20 antibody fragment) protein.
BiPUP BiP-bound generic unfolded protein.
BiPUscFv BiP-bound unfolded scFv protein.
Cytoplasmic scFv mRNA Cytoplasmic scFv mRNA.
Cytoplasmic UscFv Cytoplasmic unfolded scFv protein.
MscFv Misfolded scFv protein.
Nuclear scFv mRNA Nuclear scFv mRNA.
PDI PDI.
PDIUP PDI-bound generic unfolded protein.
PDIUscFv PDI-bound unfolded scFv protein.
ptt’ing UscFv Post-translational translocating unfolded scFv protein.
scFv mRNA scFv mRNA.
SscFv Secreted scFv.
UscFv Unfolded scFv protein.
UP Generic unfolded protein within the ER, excluding scFv.
State preﬁx Signiﬁcance
M- Misfolded.
S- Secreted.
U- Unfolded.
d½SscFv=dt subscript Subscript deﬁnition
-nominal No BiP or PDI overexpressed.
-O.BiP BiP overexpressed.
-O.BiP1PDI Both BiP and PDI overexpressed.
-O.PDI PDI overexpressed.
-SS Steady-state.
Icon description Icon deﬁnition
Double-headed arrow Indicates reversible reaction.
k– Rate constant deﬁned in Table 3.
Multiplication sign Indicates an additional reactant in a second-order reaction.
Orange sunburst BiP.
Pink/turquoise banana-shape PDI acting as a foldase.
Pink/turquoise tooth-shape PDI acting as a chaperone.
Plus sign Indicates additional products of a reaction.
Red box containing text ‘‘VscFv’’ scFv mRNA input.
Red curved line bundle Folded scFv destined for secretion (SscFv).
Red oval containing text scFv state deﬁned by text.
Red sun containing text ‘‘deg.’’ Indicates degradation of the reactant.
Single-headed arrow Indicates irreversible reaction.
Turquoise oval containing text Generic unfolded protein state deﬁned by text.
Rate constant subscript preﬁx/sufﬁx Signiﬁcance
-b Speciﬁc to a three-state model.
-bit BiP-independent translocation into the ER.
(-)d Degradation.
m- Misfolding rate.
r- Reverse reaction rate.
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tion of experimental behaviors: translocation by BiP and
branched folding by PDI that competed with degradation.
The added details only elaborated, but did not alter, these
basic processes. Consequently, predictions could be made for
large groups of parameters within the processes as to how
they would affect SscFv production.
Starting with the PDI folding/degradation competition
process, it would follow that changes in parameters associated
with folding would similarly affect SscFv production, and
changes in parameters associated with misfolding would in-
versely affect production. Thus, increasing folding rates and
decreasing misfolding rates would be expected to increase
SscFv production. Additionally, adjusting BiP- and PDI-
UscFv binding/ dissociation rates so as to increase the produc-
tion of the fastest folding, slowest misfolding UscFv binding
state (BiPPDIUscFv) over slower folding and faster mis-
folding states would also increase SscFv production. Indeed,
these predictions were veriﬁed when the parameter alterations
were implemented in the mathematical model (see Fig. 7,
which shows the relative SscFv dependencies to the various
folding, misfolding, binding, and dissociation rates). Relative
overall misfolded scFv production dependencies were simply
the inverse of these results (not shown).
Similar predictions and veriﬁcations could be performed
for parameter dependencies in the BiP translocation process.
In a logical fashion, it could be anticipated that increases/
decreases in parameters associated with transcription and
translation would result in increased/decreased SscFv pro-
duction (veriﬁcation not shown). However, there was one
parameter that proved to be critical to model performance: the
rate at which the translocation complex formed, which in-
cluded UscFv trafﬁcking to the translocon and BiP binding to
it in a second-order reaction. Reasoning predicts that low
values of this parameter would limit the translocation process,
TABLE 3 Parameters deﬁnitions, values, and references
Developing
models
parameter
Detailed
model
parameters Deﬁnition Value Units Reference(s)
k1 N/A Effective second-order rate constant for scFv translation and
translocation into the ER by bound BiP.
1.2 3 108 1=(molecules  s) (32,84,86)
k1b N/A Effective second-order rate constant for scFv translation and
BiP-catalyzed translocation into the ER.
1.2 3 108 1=(molecules  s) (32,84,86)
k1bit N/A Effective ﬁrst-order rate constant for scFv translation and
BiP-independent translocation into the ER.
4.0 3 103 1=s (32,84,86)
k2 k61 PDI-UscFv binding rate. 2.3 3 10
7 1=(molecules  s) (71–73)
k2b N/A PDI-catalyzed UscFv folding rate. 1.6 3 10
7 1=(molecules  s) (36,67,68,71–73)
kr2 kr61 PDI-UscFv release rate. 6.0 3 10
4 1=s (71–73)
k3 k63 BiPUscFv folding rate. 7.0 3 103 1=s (36,67,68)
kd k3d Cytoplasmic scFv mRNA degradation rate. 2.6 3 10
3 1=s (85)
km3 km63 BiPUscFv misfolding rate. 3.9 3 102 1=s (36,67,68)
k4 k65 BiPPDIUscFv folding rate. 3.4 1=s (36,67,68)
km4 km65 BiPPDIUscFv misfolding rate. 3.9 3 102 1=s (36,67,68)
k5 k66 PDIUscFv folding rate. 8.5 3 102 1=s (36,67,68)
km5 km66 PDIUscFv misfolding rate. 3.4 3 101 1=s (36,67,68)
k6 k60 BiP-UscFv binding rate. 1.2 3 10
8 1=(molecules  s) (86)
kr6 kr60 BiP-UscFv release rate. 1.0 3 10
1 1=s (86,87)
k7 k64 UscFv folding rate. 7.0 3 10
3 1=s (36,67,68)
km7 km64 UscFv misfolding rate. 3.4 3 10
1 1=s (36,67,68)
N/A k55 scFv mRNA nuclear translocation rate. 1.8 1=s (74–80)
N/A k56 scFv translation rate. 6.2 3 10
2 1=s (81,82)
N/A k58 UscFv trafﬁcking rate to the translocon. 2.2 3 10
9 1=(molecules  s) (83)
N/A k59 UscFv posttranslational translocation rate. 9.0 3 10
1 1=s (84)
N/A k69 BiP-unfolded protein binding rate. 8.8 3 10
2 1=(molecules  s) (S. Hildebrandt,
D. Raden,
A. S. Robinson,
and F. J. Doyle III,
unpublished)
N/A kr69 BiP-unfolded protein release rate. 1.0 3 10
1 1=s (S. Hildebrandt,
D. Raden,
A. S. Robinson,
and F. J. Doyle III,
unpublished)
N/A k70 PDI-unfolded protein binding rate. 2.3 3 10
7 1=(molecules  s) (71–73)
N/A kr70 PDI-unfolded protein release rate. 6.0 3 10
4 1=s (71–73)
N/A k76 PDI-unfolded protein binding rate as a chaperone. 2.3 3 10
7 1=(molecules  s) (71–73)
N/A kr76 PDI-unfolded protein release rate as a chaperone. 3.2 3 10
1 1=s (41,71–73)
N/A k57 Cytoplasmic UscFv degradation rate. 4.0 3 10
4 1=s (69)
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so SscFv production would be highly BiP-dependent. High
values of this parameter would ﬂood the ER with UscFv, so
SscFv production would become folding—hence, PDI—
limited. Consequently, this parameter could potentially dictate
relative SscFv dependencies to BiP and PDI levels.
To verify this prediction, SscFv levels at 50 h were plotted
against the experimental measurements for a range of trans-
location complex formation rates for various BiP and PDI
overexpression levels, as shown in Fig. 8. In the plots it may be
observed that, indeed, there is a gradual transition from total
BiP dependence to total PDI dependence by SscFv production
as the translocation rate increases. It is only within an inter-
mediate range, at ;2.2 3 109 1=(molecules  s); that BiP
and PDI dependencies are comparable. (The literature-derived
value, 1.2 3 108 1=(molecules  s); used in model develop-
ment falls within this range.) Since the value of this parameter
is so critical for reproducing experimentally observed BiP and
PDI dependencies, it becomes one ﬁnal model requirement:
Requirement No. 3
The rate constant associated with the second-order BiP-de-
pendent reaction step in translocation must not be so low
compared to PDI-dependent folding rates that it excessively
ampliﬁes BiP over PDI expression level dependency. It also
should not be so high that it eliminates BiP dependency al-
together and makes the system PDI folding-dependent.
It is important to note that Fig. 8 and Requirement No. #3
suggest that relative secreted scFv dependencies on BiP and
PDI concentrations are not robust to perturbations in the
translocation rate constant. Robustness has been hypothe-
sized to be a key feature of biological regulatory systems,
which contain control elements responsible for conferring
robustness on these systems (44,45). The isolated scFv
folding model presented here lacks any such elements, so its
consequent lack of robustness is not surprising. Biologically,
the protein folding process is regulated by the unfolded
protein response (reviewed in (46,47)), which does contain
control elements that increase protein folding robustness.
Prill et al. (20) has also hypothesized robustness to be a
feature of recurring biological motifs, which is supported by
the branched dependency-degradation competition motif, but
warn that a motif that expresses robustness in isolation may
not necessarily pass along that robustness to the entire sys-
tem, which is also observed in this work.
CONCLUSIONS
In this work, a top-down approach to mechanistic modeling
was presented and its implementation demonstrated through
the development of a mathematical model for scFv folding in
S. cerevisiae ER by BiP and PDI. This approach, represented
schematically in Fig. 1, may be summarized as follows:
1. Establish the training data (i.e., the experimental data the
mathematical model is expected to reproduce).
2. Establish the scope of the model (i.e., the biological
details that the model will include).
3. Develop and analyze a backbone model (i.e., the most
basic abstraction of the biological system that can
reproduce the desired behaviors), potentially from
known biological behavior motifs.
4. Incrementally append the backbone model with desired
biological details and evaluate their effects on model
performance until the desired level of mechanistic detail
has been achieved.
FIGURE 7 Relative SscFv production depen-
dency on UscFv folding and misfolding and
BiP- and PDI-UscFv binding/release rate pa-
rameters, as deﬁned in Table 3 and depicted in
Fig. 6. Generally, parameter numbers with a
corresponding r are binding rates, and the r rates
are dissociation rates; parameter numbers with a
corresponding m are folding rates, and the m
rates are misfolding rates (see Table 2). SscFv
levels were measured at 50 h.
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As part of the model development, the importance of anno-
tating all assumptions and simpliﬁcations was emphasized, as
systematic alteration and relaxation of these assumptions and
simpliﬁcations could be used to conclusively eliminate
poorly performing model formulations.
When it was employed to develop a mechanistic mathe-
matical model for scFv folding based on the Xu et al. (29)
hypothesis, the strength of the top-down approach was dem-
onstrated. The approach identiﬁed three requirements and a
biological behavior motif necessary to reproduce experimen-
tally observed BiP and PDI dependencies and augmented scFv
production with combined BiP and PDI overexpression, thus
supporting the hypothesis in these capacities. It also identiﬁed
a shortcoming in the hypothesis, in that it cannot capture syn-
ergistic interactions between BiP and PDI in the scFv folding
process. Elucidation of the requirements and motif, which
naturally arose as part of the top-down process, would not
have been so straightforward had a bottom-up approach been
implemented. The requirements are reiterated below:
Requirement No. 1
Competition between degradation/misfolding and acceler-
ated folding by PDI is necessary for PDI dependence.
Requirement No. 2
Assuming post-translational translocation is BiP-dependent,
competition between the translocation step and cytoplasmic
degradation of the translocating species is required to make
BiP and PDI expression level dependencies comparable.
Requirement No. 3
The rate constant associated with the second-order BiP-de-
pendent reaction step in translocation must not be so low
compared to PDI-dependent folding rates that it excessively
ampliﬁes BiP over PDI expression level dependency. It also
should not be so high that it eliminates BiP dependency al-
together and makes the system PDI folding-dependent.
The scFv folding example is elementary in its size and
complexity and in the amount of biological information readily
available for model construction, but the top-down approach is
applicable to systems of all sizes with all amounts of available
biological information. One key to any successful modeling
effort is the proper alignment of model scope with the amount
of available information and goal(s) of model construction.
Gradually applying detail to a highest-level model systemati-
cally heeds this charge by enabling the modeler to straight-
forwardly identify when the model is becoming needlessly
and/or impractically bulky, especially with respect to available
biological data and questions being asked of it. Even when
systems become necessarily large and/or difﬁcult to solve, the
approach intimates the modeler with the modeling aspects that
are pushing the ever-increasing upper bounds of computer
technology (e.g., speed, memory, parallelization) and software
(e.g., solvers for ordinary and differential-algebraic systems of
equations, such as those within the powerful DASPK (48) and
SUNDIAL (49)) capability, so a precise plan of action may be
developed to cope with them.
One challenge present in the top-down approach is the
possibility of missing certain mechanistic components or
FIGURE 8 Plots demonstrating SscFv pro-
duction dependency on the rate at which
cytoplasmic UscFv was trafﬁcked to the trans-
locon (k58) for double BiP and PDI (A), triple
BiP and PDI (B), and quadruple BiP and PDI
(C) overexpression levels. SscFv levels were
measured at 50 h and compared to the experi-
mental values (dashed lines). Error bars for the
experimental data are provided on one experi-
mental data point for ease of interpretation but
apply to all: O.BiP1PDI and O.BiP error bars
are found at k58 ¼ 1:23 1091=(molecules  s);
O.PDI, at 2:23 1091=(molecules  s); and
nominal, at 3:23 1091=(molecules  s):
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biological behavior motifs if their effects are masked within
the data used to construct the model. For example, a feed-
forward regulatory loop may be overlooked if its inﬂuence on
existing experimental data is adequately captured by em-
ploying a large value for one of the parameters when the
precise value is unknown. Generally, this challenge may be
addressed by comparing mechanistic model parameter values
to known values for particular classes of reactions for dis-
crepancies (e.g., check if a model’s phosphorylation rate
falls within the known range of values for this type of reac-
tion). This parameter-check may also be used as a means of
evaluating model performance. Additionally, and perhaps
more importantly, an incomplete model produced by the top-
down approach that captures known experimental behaviors
is not technically invalid, unless experimental conditions in
which the inﬂuence of the missing components or biological
behavior motifs plays a critical role are deﬁned and the in-
ﬂuence observed. Again, the top-down approach offers
the beneﬁt of preventing the model from becoming overly-
detailed relative to the amount of available information
and the questions being asked of it. The process of amending
a model with more biological information as it becomes
available falls into the general framework of iterative,
hypothesis-driven research in systems biology (1). Finally,
one way to protect against overlooking the inﬂuence of a
particular biological behavior motif is by ensuring that
known motifs and their behaviors are thoroughly character-
ized for a wide range of conditions and parameter values, a
task that has been undertaken for a variety of feedforward
loop types (50–52) in the case of the feedforward loop
example.
The ﬁeld of systems biology is only recently emerging
as a viable means for studying biological systems, thanks
to recent advances in experimental data gathering and
analysis techniques and tools (53). As the ﬁeld continues
to develop and become more standardized, a systema-
tization of the approaches to mathematical modeling of
biological systems will assist in this standardization. As
these approaches are systematized, formal comparisons
and evaluations of their appropriateness and performance
for use in modeling particular systems will most certainly
arise.
It is even possible that, eventually, certain aspects of
modeling approach selection and implementation will be-
come fully automated. Speciﬁc to the implementation of the
top-down approach to mechanistic modeling, much effort is
being placed into developing literature and database mining
algorithms and software (54–58) to enumerate experimen-
tally observed species interactions—a potential means of
automating the process of deﬁning model scope. If a formal
biological behavior motifs database were ever to be com-
piled, algorithms and software could be developed to mine it
for motifs for use in backbone model construction as well.
Another approach may be the creation and cataloguing of a
biological behavior motifs database using an algorithm
similar to that developed and implemented by Francxois and
Hakim (59), which constructs basic modules and motifs from
scratch (excluding even biologically known parameter
values) to capture prescribed biological behaviors. The
Francxois and Hakim (59) evolutionary procedure may even
be adapted to automate the process of appending a backbone
model with mechanistic detail and assessing the effects on
model performance, much the way attempts have been made
to automate model reduction in bottom-up approaches to
mechanistic modeling (60–64). Similarly, the top-down ap-
proach may borrow methods, such as those from metabolic
engineering (65,66), to systematically explore the effects of
altering model connectivity. Indeed, this work takes only an
initial step into the systematization of mechanistic biological
modeling, with much work yet to be done.
APPENDIX
Nomenclature
Table 2 enumerates deﬁnitions for all states, state preﬁxes, and preﬁxes
and sufﬁxes used in parameter subscript labels in model equations and Figs. 3
and 6 for straightforward interpretations of these model descriptions. Note
that the brackets around the state names found in the equations simply
indicate concentrations, which were always expressed in terms of number of
molecules. The table also provides a legend for all of the characters used in
the ﬁgures. Finally, all parameter deﬁnitions and values may be found in
Table 3.
Parameter derivations
k3/k63, km3/km63, k7/k64, km7/km64, k4/k65, km4/km65, k5/k66, and
km5/km66, UscFv folding and misfolding rates
For Fab antibody fragments, Mayer et al. (36) measured 2% nominal folding,
15% folding with BiP and ATP, 20% folding with PDI, and 40% folding
with BiP, PDI, and ATP. These folding percentages were assumed to be
loosely applicable to 4-4-20 scFv fragment folding, since Nieba et al.
(67) has reported 2% nominal folding when the fragment is expressed in E.
coli. Freund et al. (68) measured a fast folding phase rate of 0:3241=min and
slow phase rate of 0:0481=min for another scFv fragment. The overall
folding rate
1
0:324
1
min
1
1
0:048
1
min
0
B@
1
CA
1
1min
60 s
¼ 7:03 1041
s
was assumed to be applicable to the 4-4-20 fragment, so this was the nominal
and BiP-assisted folding rate (k3/k63 and k7/k64) used in the mathematical
models. The remaining folding rates could be derived from the collected
information:
2%
98%
¼ 7:03 10
41
s
km7=km64; km5=km66
0km7=km64; km4=km65; km5=km66
¼ 3:43 1021
s
; (15)
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15%
85%
¼ 7:03 10
41
s
km3=km63; km4=km65
0km3=km63 ¼ 3:93 1031
s
; (16)
20%
80%
¼ k5=k66
3:43 1021
s
0k5=k66 ¼ 8:53 1031
s
; (17)
50%
50%
¼ k4=k65
3:43 1021
s
0k4=k65 ¼ 3:43 1021
s
: (18)
To accelerate folding dynamics, all of these rate constant values were
multiplied by a factor of 10. Further, k4/k65 was multiplied by another factor
of 10 to emphasize the increase in folding rate caused by BiP and PDI
binding.
k6/k60, kr6/kr60, k69, kr69, k2/k61, kr2/kr61, k70, kr70, k76, and kr76,
BiP- and PDI-UscFv and general unfolded protein binding
and dissociation rates
k6/k60 and kr6/kr60 are taken directly from Robinson and Lauffenburger (69),
with the original references provided in Table 3. Units conversion was
implemented using 4:3531015L=ER:BiP-general unfolded protein binding
and release rates were taken directly from S. Hildebrandt, D. Raden, A. S.
Robinson, and F. J. Doyle III, unpublished, which used an optimized value
for binding, and the Robinson and Lauffenburger (69) value for release.
Darby and Creighton (71) measured a PDI binding rate of 600 1=(M  s);
which converts to k2=k61; k70 ¼ 2:331071=(molecules  s): Primm and
Gilbert (72) and Puig et al. (73) measured the dissociation constant for
various forms of PDI from various substrates to be ;1 mM, which converts
to 2.62 3 103 molecules. This value was used to calculate the dissociation
rate: kr2=kr61; kr70 ¼ ð1:623103 moleculesÞð2:331071=(molecules  s)Þ ¼
6:031041=s:
For PDI chaperone binding/dissociation, Gilbert (41) reviewed dissoci-
ation constants ranging from 50 to 1000mM.The average of these values was
used: 1.31 3 106 molecules, after units conversion. The chaperone binding
rate was arbitrarily taken to be identical to the foldase binding rate ðk76 ¼
2:331071=(molecules  s)Þ: The consequent chaperone release rate was
then 3:231011=s:
k55, k56, k58, and k59, scFv translation and transport rates
Ribbeck and Go¨rlich (74), Siebrasse and Peters (75), and Smith et al. (76)
place nuclear translocation at a rate of ;100 MDa=(s  NPCmolecule) in
various vertebrates for various molecules. Ribbeck and Go¨rlich (74) mea-
sured 2800 NPC molecules in the nuclear envelope of HeLa cells. These
values were combined to produce a general value for the nuclear transloca-
tion rate, 2.8 105MDa=s; which was assumed to apply to S. cerevisiae.
Calapez et al. (77), Lukacs et al. (78), Shav-Tal et al. (79), and Politz et al.
(80) measured diffusion rates for a variety of species in the nucleus, including
DNA, mRNA, and nascent ribosomes, to be;1mM=s:Given an estimated S.
cerevisiae nuclear volume of 1.74 3 1015 L and an assumption of nuclear
sphericity, the characteristic area (Ær2æ) of the nucleus may be calculated:
Ær2æ ¼ 3
4p
ð1:743 1015 LÞ 10
15
mm
3
L
  2=3
¼ 0:56 mm2:
(19)
The resulting effective diffusion rate was then
1
mM
s
0:56mm
2 ¼ 1:8
1
s
: (20)
Combining the diffusion rate with the nuclear translocation rate and the
molecular weight of scFv mRNA (0.3200024 MDa) gave an overall nuclear
translocation rate of
k55 ¼ 1
2:83 105MDa
s
0:320024MDa
0
@
1
A
1
1
1:8
1
s
0
BBBBBB@
1
CCCCCCA
1
¼ 1:8 1
s
: (21)
Although ribosome occupancy density does not necessarily scale linearly
with mRNA length (81), this assumption was made for simpliﬁcation
purposes. Using extrapolation points from Arava et al. (81), ribosome
occupancy density could be estimated from the 963-nt-long scFv fragment
mRNA:
1:2
ribosomes
100 nts
 0:14 ribosomes
100 nts
400 nts 3600 nts ¼
1:2
ribosomes
100 nts
 X ribosomes
100 nts
400 nts 963 nts 0X¼ 1:01
ribosomes
100 nts
: (22)
From this density, it could be estimated that there is an average of 10
ribosomes on the scFv fragment mRNA. Freedman (82) estimated an overall
translation rate of 2aa=s: The scFv fragment mRNA is 321-amino-acids long,
so the overall scFv translation rate is k56 ¼ (10 ribosomes32aa=s)=321 aa ¼
6:231021=s:
Goder et al. (83) estimated SRP binding and trafﬁcking to the translocon
to take place at a rate of 3:41=s: The parameter k58 also includes BiP binding at
the translocon, which occurs at a rate of k6/k60¼ 1.23 108 1=(molecules  s):
Combining these two rates provides the overall rate constant:
k58 ¼ 11
ð3:4 sÞð3:373 105 BiPmoleculesÞ
0
BB@
1
1
1:23 108
1
molecules  s
1
CA
1
¼ 1:23 108 1
molecules  s: (23)
The value in the table is optimized for desired secreted scFv dependencies on
BiP and PDI levels, as discussed in the text.
Theoretical analyses by Elston (84) place translocation at a rate of
;100nm=s: The average length of an amino acid is 0.35 nm, and the scFv
fragment protein length is 317 amino acids. Thus, k59 is 9:03 10
11=s:
kd/k3d, scFv mRNA degradation rate
As an approximation for scFv mRNA degradation, Oliveira and McCarthy
(85) gives half-lives for a variety of mRNAs ranging from 1.5 to 7.5 min. The
average of 4.5 min gave a ﬁrst-order rate constant of (ln2=4:5min)3
(1min=60 s) ¼ 2:63 1031=s; which was used to for k3d.
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k1b, k1bit, and k2b, developing models rates
The value k1b encompasses the processes involved with k55, k56, k58, and k59.
The value k58 largely remained the rate-limiting step, so its derived value,
1.23 108 1=(molecules  s);was used in these models. The value k1bit is the
equivalent rate without BiP dependence, so this dependencemay be removed
by the multiplication by 3.37 3 105 BiP molecules. Thus, k1bit ¼
4:031031=s: The value k2b was taken to be k5 /k66, made PDI-dependent
by dividing by 5.24 3 105 PDI molecules.
Model equations
Model 1
d½UscFv
dt
¼ k1b½scFvmRNA½BiP  k2b½UscFv½PDI; (24)
d½SscFv
dt
¼ k2b½UscFv½PDI; (25)
d½SscFv
dt
 
SS
¼ k1b½BiP½scFvmRNA: (26)
Model 2
d½UscFv
dt
¼ k1b½scFvmRNA½BiP  k2b½UscFv½PDI
 km5½UscFv; (27)
d½SscFv
dt
¼ k2b½UscFv½PDI; (28)
d½SscFv
dt
 
SS
¼ k1b½BiP½scFvmRNA½PDI
km5
k2b
1 ½PDI
: (29)
Model 3
d½BiP  UscFv
dt
¼ k1½scFvmRNA½BiP1 kr2½BiP  PDI
 UscFv  k2½PDI½BiP  UscFv
 ðk31 km3Þ½BiP  UscFv; (30)
d½BiP  PDI  UscFv
dt
¼ k2½PDI½BiP  UscFv  kr2½BiP
 PDI  UscFv  ðk41 km4Þ
3 ½BiPPDI  UscFv; (31)
d½BiP
dt
¼ ðk31 km3Þ½BiP  UscFv1 ðk41 km4Þ½BiP
 PDI  UscFv  k1½scFvmRNA½BiP; (32)
d½PDI
dt
¼ ðk41 km4Þ½BiP  PDI  UscFv1 kr2½BiP
 PDI  UscFv  k2½PDI½BiP  UscFv; (33)
d½SscFv
dt
¼ k3½BiP  UscFv1 k4½BiP  PDI  UscFv; (34)
d½SscFv
dt
 
SS
¼ k1½BiP½scFvmRNAðk3ðkr21 k41 km4Þ1 k2½PDIk4Þðk31 km3Þðkr21 k41 km4Þ1 k2½PDIðk41 km4Þ :
(35)
Model 3*
d½scFvmRNA
dt
¼ VscFv  kd½scFvmRNA
 k1½scFvmRNA½BiP; (36)
d½BiP  UscFv
dt
¼ k1½scFvmRNA½BiP1 kr2½BiP  PDI
 UscFv  k2½PDI½BiP  UscFv
 ðk31 km3Þ½BiP  UscFv; (37)
d½BiP  PDI  UscFv
dt
¼ k2½PDI½BiP  UscFv  kr2½BiP
 PDI  UscFv  ðk41 km4Þ½BiP
 PDI  UscFv; (38)
d½BiP
dt
¼ ðk31 km3Þ½BiP  UscFv1 ðk41 km4Þ½BiP
 PDI  UscFv  k1½scFvmRNA½BiP; (39)
d½PDI
dt
¼ ðk41 km4Þ½BiP  PDI  UscFv1 kr2½BiP  PDI
 UscFv  k2½PDI½BiP  UscFv; (40)
d½SscFv
dt
¼ k3½BiP  UscFv1 k4½BiP  PDI  UscFv; (41)
d½SscFv
dt
 
SS
¼ VscFvk1½BiPðk3ðkr21k41km4Þ1k2½PDIk4Þðk1½BiP1kdÞððk31km3Þðkr21k41km4Þ1k2½PDIðk41km4ÞÞ:
(42)
Model 4
d½UscFv
dt
¼ kr6½BiP  UscFv  k6½BiP½UscFv
 ðk71 km7Þ½UscFv; (43)
d½BiP  UscFv
dt
¼ k1½scFvmRNA½BiP1 kr2½BiP  PDI
 UscFv  k2½PDI½BiP  UscFv
1 k6½BiP½UscFv  kr6½BiP  UscFv
 ðk31 km3Þ½BiP  UscFv; (44)
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d½BiP PDI UscFv
dt
¼ k2½PDI½BiP UscFv
 kr2½BiP PDI UscFv
 ðk41 km4Þ½BiP PDI UscFv; (45)
d½BiP
dt
¼ ðk31 km3Þ½BiP  UscFv1 ðk41 km4Þ½BiP
 PDI  UscFv1 kr6½BiP  UscFv
 k6½BiP½UscFv  k1½scFvmRNA½BiP; (46)
d½PDI
dt
¼ ðk41 km4Þ½BiP  PDI  UscFv1 kr2½BiP
 PDI  UscFv  k2½PDI½BiP  UscFv; (47)
d½SscFv
dt
¼ k7½UscFv1 k3½BiP  UscFv
1 k4½BiP  PDI  UscFv; (48)
Model 4*
d½scFvmRNA
dt
¼ VscFv  kd½scFvmRNA
 k1½scFvmRNA½BiP; (50)
d½UscFv
dt
¼ kr6½BiP  UscFv  k6½BiP½UscFv
 ðk71 km7Þ½UscFv; (51)
d½BiP UscFv
dt
¼ k1½scFvmRNA½BiP1kr2½BiP
PDIUscFv k2½PDI½BiP UscFv
1k6½BiP½UscFv kr6½BiP UscFv
 ðk31km3Þ½BiP UscFv;
(52)
d½BiP PDI UscFv
dt
¼ k2½PDI½BiP UscFv
 kr2½BiP PDI UscFv
 ðk41km4Þ½BiP PDI UscFv; (53)
d½BiP
dt
¼ ðk31km3Þ½BiP UscFv1ðk41km4Þ
3 ½BiP PDI UscFv1kr6½BiP UscFv
 k6½BiP½UscFv k1½scFvmRNA½BiP; (54)
d½PDI
dt
¼ ðk41km4Þ½BiP PDI UscFv1kr2½BiP
PDI UscFv k2½PDI½BiP UscFv; (55)
d½SscFv
dt
¼ k7½UscFv1k3½BiP UscFv
1k4½BiP PDI UscFv; (56)
Model 5
d½BiP UscFv
dt
¼ k1½scFvmRNA½BiP1kr2½BiP
PDI UscFv k2½PDI½BiP
UscFv ðk31km3Þ½BiP UscFv; (58)
d½SscFv
dt
 
SS
¼
k1½BiP½scFvmRNA k31 k4k2½PDI
kr21 k41 km4
1
k7kr6
k6½BiP1 k71 km7
 
kr6 1 k6½BiP
k6½BiP1 k71 km7
 
1 k2½PDI 1 kr2
kr21 k41 km4
 
1 k31 km3
: (49)
d½SscFv
dt
 
SS
¼
VscFvk1½BiP k31 k4k2½PDI
kr21 k41 km4
1
k7kr6
k6½BiP1 k71 km7
 
ðk1½BiP1 kdÞ kr6 1 k6½BiP
k6½BiP1 k71 km7
 
1 k2½PDI 1 kr2
kr21 k41 km4
 
1 k31 km3
 : (57)
d½PDI  UscFv
dt
¼ kr6½BiP  PDI  UscFv
 k6½BiP½PDI  UscFv
 ðk51 km5Þ½PDI  UscFv; (59)
d½BiP  PDI  UscFv
dt
¼ k2½PDI½BiP  UscFv  kr2½BiP  PDI  UscFv
1 k6½BiP½PDI  UscFv  kr6½BiP  PDI  UscFv
 ðk41 km4Þ½BiP  PDI  UscFv; (60)
d½BiP
dt
¼ ðk31 km3Þ½BiP  UscFv1 ðk41 km4Þ½BiP  PDI
 UscFv1 kr6½BiP  PDI  UscFv  k6½BiP½PDI
 UscFv  k1½scFvmRNA½BiP; (61)
d½PDI
dt
¼ ðk41 km4Þ½BiP  PDI  UscFv1 ðk51 km5Þ
3½PDI  UscFv1 kr2½BiP  PDI  UscFv
 k2½PDI½BiP  UscFv; (62)
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Model 5*
d½scFvmRNA
dt
¼ VscFv  kd½scFvmRNA
 k1½scFvmRNA½BiP; (65)
d½BiP UscFv
dt
¼ k1½scFvmRNA½BiP1kr2½BiP
PDI UscFv k2½PDI½BiP
UscFv ðk31km3Þ½BiP UscFv; (66)
d½PDI UscFv
dt
¼ kr6½BiP PDI UscFv k6½BiP½PDI
UscFv ðk51km5Þ½PDI UscFv; (67)
d½BiP PDI UscFv
dt
¼ k2½PDI½BiP UscFv kr2½BiP PDI UscFv
1k6½BiP½PDI UscFv kr6½BiP PDI UscFv
 ðk41km4Þ½BiP PDI UscFv; (68)
d½BiP
dt
¼ ðk31km3Þ½BiPUscFv1ðk41km4Þ½BiPPDI
UscFv1kr6½BiP PDI UscFv k6½BiP
3½PDI UscFv k1½scFvmRNA½BiP; (69)
d½PDI
dt
¼ ðk41km4Þ½BiP PDI UscFv1ðk51km5Þ
3½PDI UscFv1kr2½BiP PDI UscFv
 k2½PDI½BiP UscFv; (70)
d½SscFv
dt
¼ k3½BiP UscFv1k5½PDI UscFv
1k4½BiP PDI UscFv; (71)
Model 6
d½SscFv
dt
 
SS
¼ k3k1½BiP½scFvmRNA
k2½PDI1 k31 km3 1
k3kr2
k2½PDI1 k31 km31 k41
k5kr6
k6½BiP1 k51 km5
 
3
k1½BiP½scFvmRNAk2½PDI
ðk2½PDI1 k31 km3Þ kr6 1 k6½BiP
k6½BiP1 k51 km5
 
1 kr2 1 k2½PDI
k2½PDI1 k31 km3
  
8><
>>:
9>=
>>;
: (64)
d½SscFv
dt
¼ k3½BiP  UscFv1 k5½PDI  UscFv1 k4½BiP  PDI  UscFv; (63)
d½SscFv
dt
 
SS
¼ k3VscFvk1½BiPðk1½BiP1 kdÞðk2½PDI1 k31 km3Þ1
k3kr2
k2½PDI1 k31 km31 k41
k5kr6
k6½BiP1 k51 km5
 
3
VscFvk1½BiPk2½PDI
ðk1½BiP1 kdÞðk2½PDI1 k31 km3Þ kr6 1 k6½BiP
k6½BiP1 k51 km5
 
1 kr2 1 k2½PDI
k2½PDI1 k31 km3
  
8>><
>:
9>>=
>;
: (72)
d½BiP
dt
¼ ðk31 km3Þ½BiP  UscFv1 ðk41 km4Þ½BiP  PDI  UscFv
1 kr6ð½BiP  UscFv1 ½BiP  PDI  UscFvÞ
 k6½BiPð½UscFv1 ½PDI  UscFvÞ  k1½scFvmRNA½BiP; (77)
d½UscFv
dt
¼ kr6½BiP  UscFv  k6½BiP½UscFv
 ðk71 km7Þ½UscFv; (73)
d½BiP UscFv
dt
¼ k1½scFvmRNA½BiP1kr2½BiP PDI
UscFv k2½PDI½BiP UscFv1k6½BiP½UscFv
 kr6½BiP UscFv ðk31km3Þ½BiP UscFv; (74)
d½PDI  UscFv
dt
¼ kr6½BiP  PDI  UscFv  k6½BiP½PDI
 UscFv  ðk51 km5Þ½PDI  UscFv; (75)
d½BiP  PDI  UscFv
dt
¼ k2½PDI½BiP  UscFv  kr2½BiP
 PDI  UscFv1 k6½BiP½PDI  UscFv  kr6½BiP
 PDI  UscFv  ðk41 km4Þ½BiP  PDI  UscFv; (76)
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d½PDI
dt
¼ ðk41km4Þ½BiP PDI UscFv1ðk51km5Þ
3½PDI UscFv1kr2½BiP PDI UscFv
 k2½PDI½BiP UscFv; (78)
d½SscFv
dt
¼ k7½UscFv1k3½BiP UscFv1k5½PDI UscFv
1k4½BiP PDI UscFv; (79)
Model 6*
d½scFvmRNA
dt
¼VscFv  kd½scFvmRNA
 k1½scFvmRNA½BiP; (81)
d½UscFv
dt
¼ kr6½BiP UscFv k6½BiP½UscFv
 ðk71km7Þ½UscFv; (82)
d½BiP UscFv
dt
¼ k1½scFvmRNA½BiP1kr2½BiPPDI
UscFvk2½PDI½BiPUscFv
1k6½BiP½UscFv kr6½BiP UscFv
 ðk31km3Þ½BiP UscFv; (83)
d½PDI UscFv
dt
¼ kr6½BiP PDI UscFv k6½BiP½PDI
UscFv ðk51km5Þ½PDI UscFv; (84)
d½BiP PDI UscFv
dt
¼ k2½PDI½BiP UscFv kr2½BiP
PDI UscFv1k6½BiP½PDI
UscFv kr6½BiP PDI UscFv
 ðk41km4Þ½BiP PDI UscFv; (85)
d½PDI
dt
¼ ðk41km4Þ½BiP PDI UscFv
1ðk51km5Þ½PDI UscFv
1kr2½BiP PDI UscFv k2½PDI½BiP UscFv;
(87)
d½SscFv
dt
¼ k7½UscFv1k3½BiP UscFv
1k5½PDI UscFv1k4½BiP PDI UscFv; (88)
d½SscFv
dt
 
SS
¼ k31 k2½PDI
kr21 kr6 1 k6½BiP
k6½BiP1 k51 km5
 
1 k41 km4
0
BB@
1
CCA
8><
>>:
3 k41
k5kr6
k6½BiP1 k51 km5
 
1
k7kr6
k6½BiP1 k71 km7
9>=
>;
3
k1½BiP½scFvmRNA
kr6 1 k6½BiP
k6½BiP1 k71 km7
 
1 k2½PDI 1 kr2
kr21 kr6 1 k6½BiP
k6½BiP1 k51 km5
 
1 k41 km4
0
BB@
1
CCA1 k31 km3
8>>>>>><
>>>>>:
9>>>>>>=
>>>>>;
; (80)
d½BiP
dt
¼ ðk31 km3Þ½BiP  UscFv1 ðk41 km4Þ½BiP  PDI  UscFv
1 kr6ð½BiP  UscFv1 ½BiP  PDI  UscFvÞ
 k6½BiPð½UscFv1 ½PDI  UscFvÞ  k1½scFvmRNA½BiP; (86)
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Model 7
d½UscFv
dt
¼ k1bit½scFvmRNA1kr6½BiP UscFv
 k6½BiP½UscFv ðk71km7Þ½UscFv; (90)
d½BiP UscFv
dt
¼ kr2½BiPPDIUscFvk2½PDI½BiPUscFv
1k6½BiP½UscFv kr6½BiP UscFv
 ðk31km3Þ½BiP UscFv; (91)
d½BiP PDI UscFv
dt
¼ k2½PDI½BiP UscFv
 kr2½BiP PDI UscFv
 ðk41km4Þ½BiP PDI UscFv;
(92)
d½BiP
dt
¼ ðk31km3Þ½BiP UscFv
1ðk41km4Þ½BiP PDI UscFv
1kr6½BiP UscFv k6½BiP½UscFv; (93)
d½PDI
dt
¼ ðk41km4Þ½BiP PDI UscFv
1kr2½BiP PDI UscFv k2½PDI½BiP UscFv;
(94)
d½SscFv
dt
¼ k7½UscFv1k3½BiP UscFv
1k4½BiP PDI UscFv; (95)
Model 8
d½scFvmRNA
dt
¼ VscFv  kd½scFvmRNA
 k1½scFvmRNA½BiP; (97)
d½UscFv
dt
¼ kr2½PDI UscFv k2½PDI½UscFv
1kr6½BiP UscFv k6½BiP½UscFv
 ðk71km7Þ½UscFv; (98)
d½BiP UscFv
dt
¼ k1½scFvmRNA½BiP1kr2½BiP PDI
UscFv k2½PDI½BiP UscFv
1k6½BiP½UscFv kr6½BiP UscFv
 ðk31km3Þ½BiP UscFv; (99)
d½PDI UscFv
dt
¼ k2½PDI½UscFvkr2½PDIUscFv1kr6½BiPPDIUscFv
 k6½BiP½PDI UscFv ðk51km5Þ½PDI UscFv; (100)
d½SscFv
dt
 
SS
¼ k7k1bit½scFvmRNA
k6½BiP1k71km7 1
k7kr6
k6½BiP1k71km71k31
k4k2½PDI
kr21k41km4
 
3
k6k1bit½BiP½scFvmRNA
ðk6½BiP1k71km7Þ kr6 1 k6½BiP
k6½BiP1k71km7
 
1k2½PDI 1 kr2
kr21k41km4
 
1k31km3
 
0
BB@
1
CCA: (96)
d½SscFv
dt
 
SS
¼ k31 k2½PDI
kr21 kr6 1 k6½BiP
k6½BiP1 k51 km5
 
1 k41 km4
0
BB@
1
CCA k41 k5kr6k6½BiP1 k51 km5
 
1
k7kr6
k6½BiP1 k71 km7
8><
>:
9>=
>;
3
VscFvk1½BiP=ðk1½BiP1 kdÞ
kr6 1 k6½BiP
k6½BiP1 k71 km7
 
1 k2½PDI 1 kr2
kr21 kr6 1 k6½BiP
k6½BiP1 k51 km5
 
1 k41 km4
0
BB@
1
CCA1 k31 km3
8>>>>><
>>>>>>:
9>>>>>=
>>>>>>;
: (89)
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d½BiP PDI UscFv
dt
¼ k2½PDI½BiP UscFv kr2½BiP PDI
UscFv1k6½BiP½PDI UscFv
 kr6½BiP PDI UscFv
 ðk41km4Þ½BiP PDI UscFv;
(101)
d½PDI
dt
¼ðk41km4Þ½BiPPDIUscFv1ðk51km5Þ½PDIUscFv
1kr2ð½PDI UscFv1 ½BiP PDI UscFvÞ
 k2½PDIð½UscFv1 ½BiP UscFvÞ; (103)
d½SscFv
dt
¼ k7½UscFv1k3½BiP UscFv
1k5½PDI UscFv1k4½BiP PDI UscFv;
(104)
L¼ kr6
kr21k6½BiP1k51km5; (105)
D¼ kr2 Mkr2k2½PDIL k6½BiPL1kr61k41km4; (107)
½BiP PDI UscFvSS
¼ ðk2½PDI1Mkr6k2½PDIÞ½BiP UscFvSS
D
; (111)
½PDI UscFvSS
¼ k2½PDI½UscFvSS1kr6½BiP PDI UscFvSS
kr21k6½BiP1k51km5 ; (112)
d½SscFv
dt
 
SS
¼ k7½UscFvSS1k3½BiP UscFvSS
1k5½PDI UscFvSS
1k4½BiP PDI UscFvSS: (113)
Detailed model
d½BiP UP
dt
¼ k69½BiP½UP kr69½BiP UP
1kr70½BiP PDI UP k70½PDI½BiP UP;
(114)
P ¼ Mðkr21 k6½BiP1 k51 km5Þðð11Mkr6Þkr2k2½PDILÞ1 kr2k2½PDI1Mkr6kr2k2½PDI
D
; (108)
½BiP  UscFvSS ¼
k1½BiPVscFv
ðk1½BiP1 kdÞðkr61 k2½PDI1 k31 km3 Mkr6ðkr21 k6½BiP1 k51 km5Þ  PÞ; (109)
M ¼ k6½BiP
k6½BiP  kr2k2½PDI
kr21 k6½BiP1 k51 km51 k2½PDI1 k71 km7
 
ðkr21 k6½BiP1 k51 km5Þ
; (106)
½UscFvSS ¼ kr61
ð11Mkr6Þkr2k2½PDIL
D
   ðMðkr21 k6½BiP1 k51 km5ÞÞ½BiP  UscFvSS
k6½BiP
 
; (110)
d½BiP
dt
¼ ðk31 km3Þ½BiP  UscFv1 ðk41 km4Þ½BiP  PDI  UscFv
1 kr6ð½BiP  UscFv1 ½BiP  PDI  UscFvÞ
 k6½BiPð½UscFv1 ½PDI  UscFvÞ  k1½scFvmRNA½BiP; (102)
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d½UP
dt
¼ kr69½BiP UP k69½BiP½UP
1kr76½PDI UP k76½PDI½UP; (116)
d½nuclear scFvmRNA
dt
¼VscFv  k55½nuclear scFvmRNA;
(118)
d½cytoplasmicscFvmRNA
dt
¼ k55½nuclear scFvmRNA
 k3d½cytoplasmicscFvmRNA;
(119)
d½cytoplasmicUscFv
dt
¼ k56½cytoplasmicscFvmRNA
 k58½BiP½cytoplasmicUscFv
 k57½cytoplasmicUscFv;
(120)
d½ptt9ingUscFv
dt
¼ k58½BiP½cytoplasmicUscFv
 k59½ptt9ingUscFv; (121)
d½BiP UscFv
dt
¼ k59½ptt9ingUscFv1kr61½BiP PDI UscFv
 k61½PDI½BiP UscFv
1k60½BiP½UscFv kr60½BiP UscFv
 ðk631km63Þ½BiP UscFv; (122)
d½UscFv
dt
¼ kr60½BiP UscFv k60½BiP½UscFv
 ðk641km64Þ½UscFv; (123)
d½MscFv
dt
¼ km64½UscFv1km63½BiP UscFv
1km66½PDI UscFv1km65½BiP PDI UscFv;
(124)
d½SscFv
dt
¼ k64½UscFv1k63½BiP UscFv
1k66½PDI UscFv1k65½BiP PDI UscFv;
(125)
d½BiP PDI UscFv
dt
¼ k61½PDI½BiP UscFv kr61½BiP PDI
UscFv1k60½BiP½PDI UscFv
 kr60½BiP PDI UscFv
 ðk651km65Þ½BiP PDI UscFv; (126)
d½PDI UscFv
dt
¼ kr60½BiP PDI UscFv
 k60½BiP½PDI UscFv
 ðk661km66Þ½PDI UscFv; (127)
d½BiP PDI UP
dt
¼ k69½BiP½PDI UP kr69½BiP PDI UP
1k70½PDI½BiP UPkr70½BiP PDI UP;
(128)
d½PDI UP
dt
¼ kr69½BiP PDI UP k69½BiP½PDI UP
 kr76½PDI UP1k76½PDI½UP: (129)
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